Tage Finninge - New Nordic Chief COO

NNH Stock  SEK 18.30  0.30  1.67%   

Insider

Tage Finninge is Chief COO of New Nordic Healthbrands
Phone46 40 23 95 20
Webhttps://www.newnordic.se

New Nordic Management Efficiency

New Nordic's management efficiency ratios could be used to measure how well New Nordic manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.24 M in total debt with debt to equity ratio (D/E) of 0.8, which is about average as compared to similar companies. New Nordic Healthbrands has a current ratio of 1.88, which is within standard range for the sector. Debt can assist New Nordic until it has trouble settling it off, either with new capital or with free cash flow. So, New Nordic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like New Nordic Healthbrands sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for New to invest in growth at high rates of return. When we think about New Nordic's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Steffen SchanzImplantica AG
N/A
Sebastian ChristeEducation Albert AB
38
Emelie GozziC Rad AB
N/A
Dan MogrenClinical Laserthermia Systems
N/A
Helena BramstorpNovotek AB
41
Xiaodong WangC Rad AB
44
Stephan MScClinical Laserthermia Systems
68
Veronika GrozdanovskaNovotek AB
53
Gunilla CornellFabege AB
54
Stefan VogtImplantica AG
58
Lars LevinC Rad AB
52
Anders HolmbergIAR Systems Group
56
Ivan AstralagaC Rad AB
N/A
BoGoran JaxeliusUSWE Sports AB
52
MalineEducation Albert AB
N/A
Trevor SaundersPolygiene AB
58
Sue BethelPolygiene AB
49
Karin PetersonClinical Laserthermia Systems
N/A
Salman EskandarieEducation Albert AB
36
Frank StevensPolygiene AB
N/A
Kajsa LernestaleEducation Albert AB
36
New Nordic Healthbrands AB develops and markets branded food supplements, natural remedies, and related personal care products. New Nordic Healthbrands AB was founded in 1990 and is based in Malm, Sweden. New Nordic operates under Healthcare Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 49 people. New Nordic Healthbrands (NNH) is traded on Stockholm Exchange in Sweden and employs 70 people.

Management Performance

New Nordic Healthbrands Leadership Team

Elected by the shareholders, the New Nordic's board of directors comprises two types of representatives: New Nordic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of New. The board's role is to monitor New Nordic's management team and ensure that shareholders' interests are well served. New Nordic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, New Nordic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tage Finninge, Chief COO
Marinus Sorensen, CoFounder Chairman
Ivan Ruscic, Chief Officer
Claes Libell, Group Relations
Karl VD, CEO CoFounder

New Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is New Nordic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with New Nordic

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if New Nordic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in New Nordic will appreciate offsetting losses from the drop in the long position's value.

Moving against New Stock

  0.66INVE-A Investor AB serPairCorr
  0.64INVE-B Investor AB serPairCorr
  0.6ORX Orexo ABPairCorr
  0.45CALTX Calliditas TherapeuticsPairCorr
The ability to find closely correlated positions to New Nordic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace New Nordic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back New Nordic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling New Nordic Healthbrands to buy it.
The correlation of New Nordic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as New Nordic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if New Nordic Healthbrands moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for New Nordic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in New Nordic Healthbrands. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Note that the New Nordic Healthbrands information on this page should be used as a complementary analysis to other New Nordic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for New Stock analysis

When running New Nordic's price analysis, check to measure New Nordic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy New Nordic is operating at the current time. Most of New Nordic's value examination focuses on studying past and present price action to predict the probability of New Nordic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move New Nordic's price. Additionally, you may evaluate how the addition of New Nordic to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Please note, there is a significant difference between New Nordic's value and its price as these two are different measures arrived at by different means. Investors typically determine if New Nordic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, New Nordic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.